FundedIQ
Biotechnology

Epic Sciences: Funding, Investors & Team (Sep 2026)

Epic Sciences is a privately held diagnostics company committed to improving cancer management by providing easily accessible and real-time biopsy material to guide personalized medicine. Epic is founded on a powerful platform to identify and characterize rare cells including circulating tumor cells ("CTCs"). Epic is working with a number of partners including numerous pharmaceutical companies, major cancer centers, the National Cancer Institute, and the National Institutes of Health.

www.epicsciences.com LinkedIn La Jolla, United States 101-250 employees
Biotechnology Health Care Health Diagnostics Hospital B2B B2C
Total raised
$67.0M
Rounds
2
Latest
Series G
Apr 2023

Epic Sciences has raised $67.0M across 2 funding rounds on record, the most recent a Series G of $24.0M announced in Apr 2023.

That round is above the $8.0M median round size for Biotechnology companies tracked on FundedIQ over the last two years.

Epic Sciences Company Profile and Key Stats

Total funding raised
$67.0M
across 2 rounds on record
Funding rounds on record
2
Latest funding round
Series G
$24.0M in Apr 2023
Employees
101-250
reported band
Headquarters
La Jolla, United States

Latest funding round on record: Apr 2023.

Epic Sciences Funding Rounds

Date
Round
Amount
Series G
$24.0M
Series F
$43.0M

Epic Sciences raised $43.0M in a Series F announced in Jun 2022.

10 months later, a Series G of $24.0M was announced in Apr 2023.

Epic Sciences Founders and Leadership Team

Name
Role
Contact
Peter Kuhn
Founder
Locked

Contact details for the Epic Sciences team: 1 of 1 has an email address on file.

Start 14-day free trial →

Epic Sciences Funding Compared to Other Biotechnology Startups

Segment
Companies
Median round
4,179
$8.0M
29,722
$7.5M
26
$333M

Epic Sciences' latest round of $24.0M is above the median round in Biotechnology. Medians cover the last 24 months of disclosed rounds.

Funded Startups Like Epic Sciences in Biotechnology and La Jolla

Companies Similar to Epic Sciences

Noveome Biotherapeutics, Inc. is an advanced biopharmaceutical company that focuses on groundbreaking…

Convertible Note $6.8M

XiltriX North America is an information technology company that specializes in monitoring, predictive…

Undisclosed round $3.0M

Novir is an emerging diagnostic biotechnology company with an unmatched team of professionals and trusted…

Seed $3.1M

Abcuro’s mission is to develop a new class of immune-modulatory bio-therapeutics for treating both…

Series D $66.0M

Georgiamune Inc. is a privately-owned biotechnology company that specializes in advanced immunotherapy…

Series B $92.7M

Bridge to Life was founded with the mission of improving organ transplants by licensing and developing new…

Series C $110M

InduPro is a biotechnology firm that focuses on protein therapeutics and technologies related to cell-surface…

Series B $77.0M

Paterna BioSciences, Inc. is a pioneering biotechnology company dedicated to solving the significant…

Series A $6.3M

Legendary Bio's solidarity is a determined spotlight on introducing another period of quality guideline.

Series C $90.0M

Cataract surgery is the single most common procedure performed in the United States annually. Despite…

Series A $7.0M

InSitu Biologics is a developer of a drug delivery platform designed to focus on development of new and…

Convertible Note $1.3M

Remedium Bio is a gene therapy company in the Boston area that is dedicated to developing cures for severe…

Series A $10.0M

Epic Sciences Funding FAQs

What does Epic Sciences do?

Epic Sciences is a privately held diagnostics company committed to improving cancer management by providing easily accessible and real-time biopsy material to guide personalized medicine. Epic is founded on a powerful platform to identify and characterize rare cells including circulating tumor cells ("CTCs"). Epic is working with a number of partners including numerous pharmaceutical companies, major cancer centers, the National Cancer Institute, and the National Institutes of Health.

How much funding has Epic Sciences raised?

Epic Sciences has raised $67.0M across 2 rounds on record. The most recent is a Series G of $24.0M announced in Apr 2023.

When did Epic Sciences last raise funding?

Epic Sciences' most recent funding round on record is a Series G of $24.0M, announced in Apr 2023.

Who founded Epic Sciences?

FundedIQ lists Peter Kuhn (Founder) at Epic Sciences.

Where is Epic Sciences headquartered?

Epic Sciences is based in La Jolla, California, United States.

How many employees does Epic Sciences have?

Epic Sciences is in the 101-250 employee band.

How does Epic Sciences' funding compare to other Biotechnology startups?

Epic Sciences' latest round of $24.0M is above the $8.0M median round size for Biotechnology companies on FundedIQ across 4,179 tracked companies over the last two years.

About FundedIQ's Epic Sciences Funding Data

FundedIQ tracks announced funding rounds and refreshes this profile every week. Round dates, stages and amounts are normalised to a single format, converted to US dollars, and de-duplicated: two records of the same round announced days apart are merged, and two genuinely different rounds are kept apart on the amounts they disclose. Amounts shown are the disclosed figures only — a round announced without a number is listed and excluded from the total rather than estimated.

Employee counts are reported bands, not exact headcounts. Founder and executive names carry the job title on record. Anything we do not hold for Epic Sciences is left off this page rather than filled in.

14-day free trial · Cancel anytime

Know who just raised. Then know who to reach.

Every newly funded startup with its round, its investors and its founders: delivered weekly by email, or searchable in the app.

Alerts from $19/mo · Pro from $99/mo. Card required, nothing charged until day 15, and we email you 3 days before that.